Powered by unique biomarkers and proprietary algorithm, the AVISE diagnostic tests like AVISE ® CTD (Connective Tissue Disease) and AVISE ® Lupus provide improved disease information compared to …

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider.

AVISE® CTD is an advanced autoimmune rheumatic disease test specifically designed to aid physicians in the differential diagnosis of systemic lupus erythematosus SLE.

Feb 26, 2019 · AVISE® CTD is a blood test that can help doctors diagnose lupus and other autoimmune diseases — like rheumatoid arthritis, Sjögren's syndrome, or scleroderma.

In the Connective Tissue Cascade, serum is tested initially for the presence of ANA and for cyclic citrullinated peptide (CCP) antibodies using solid-phase immunoassays (SPAs).

A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and …

Jan 3, 2025 · Introduced in 2012, the AVISE CTD test is a resource for diagnosing connective tissue diseases (CTDs) such as SLE, RA, Sjögren’s disease, and systemic sclerosis.

With over 30 biomarkers carefully selected by rheumatologists for their diagnostic relevance, AVISE CTD helps improve diagnostic accuracy, reducing uncertainty and aiding in earlier diagnosis.

Clinically relevant CTD assays, made with the quality you expect. Make a difference aiding in the diagnosis of connective tissue disease and order EliA TM CTD assays for laboratory testing today.

AVISE CTD combines AVISE Lupus, a 10-marker diagnostic test designed to help rule-in or rule-out lupus, with an expanded connective tissue disease panel to aid in the differential diagnosis of other …